Interleukin 16 (IL-16) is a cytokine that is primarily associated with CD4 + T cell function, but also exists as a multi-domain PDZ protein expressed within cerebellar and hippocampal neurons. We have previously shown that lymphocyte-derived IL-16 is neuroprotective against excitotoxicity, but evidence of how it affects neuronal function is limited. Here, we have investigated whether IL-16 modulates neuronal excitability and synaptic activity in mouse primary hippocampal cultures. Application of recombinant IL-16 impairs both glutamateinduced increases in intracellular Ca 2+ and sEPSC frequency and amplitude in a CD4-and CD9-independent manner. We examined the mechanisms underlying these effects, with rIL-16 reducing GluA1 S831 phosphorylation and inhibiting Na + channel function. Taken together, these data suggest that IL-16 reduces neuronal excitability and synaptic activity via multiple mechanisms and adds further evidence that alternative receptors may exist for IL-16.
interleukin-1β (IL-1β), IL-6 and tumour necrosis factor-α (TNF-α). Indeed, these cytokines are linked to the modulation of synaptic plasticity, learning and memory as well as disease development (Donzis and Tronson, 2014; Gruol, 2015; Vezzani and Viviani, 2015) .
In addition to these well-studied cytokines, other cytokines are linked to inflammation-related CNS disorders, but their exact functional role remains unclear. One such cytokine is IL-16, originally known as lymphocyte chemoattractant factor (LCF). IL-16 was identified as a Tcell-derived cytokine that induces CD4-dependent migration and proliferation of immune cells (Center and Cruikshank, 1982; Parada et al., 1998; Liu et al., 1999 ), but we now know that IL-16 is also produced by other immune cells including B cells and monocytes (Kaser et al., 2000; Elssner et al., 2004) . In addition, we recently revealed that immune cell-derived IL-16 is neuroprotective against kainate-and oxygen-glucose deprivation (OGD)-induced excitotoxicity in organotypic slice cultures (Shrestha et al., 2014) . Finally, in keeping with the intense interest in the role of cytokines in CNS disorders, recent studies have proposed that IL-16 plays a role in AD, relapsing MS and experimental autoimmune encephalomyelitis (EAE, Anvar et al., 2015; Skundric et al., 2015) . Interestingly, in addition to its role in inflammation, a neuronal variant exists as a longer splice variant of the immune cellderived IL-16 precursor protein, pro-IL-16, with two extra PDZ domains in the N-terminal region (Kurschner and Yuzaki, 1999) . Neuronal , which is selectively expressed in hippocampal and cerebellar neurons, is cleaved by caspase-3 similar to pro-IL-16 in immune cells and results in the release of mature IL-16 (Kurschner and Yuzaki, 1999) . Furthermore, NIL-16 induces the upregulation of the transcription factor c-fos, (Kurschner and Yuzaki, 1999; Fenster et al., 2010) , enhances neurite outgrowth (Fenster et al., 2010) and interacts with neurotransmitter receptors and several ion channel proteins (Kurschner and Yuzaki, 1999; Fenster et al., 2007) .
Despite these recent findings, whether IL-16 modulates hippocampal neuronal excitability and synaptic transmission remains unclear. In the present study, we reveal that in mouse hippocampal cultures, recombinant mouse IL-16 (rIL-16) impairs glutamate-induced increases in neuronal intracellular calcium (n [Ca 2+ ] i ) and inhibits the frequency and amplitude of spontaneous excitatory postsynaptic currents (EPSCs). These IL-16 mediated effects, which in contrast to previous reports are CD4-independent, are associated with a reduction in Na + channel function and reduced GluA1 phosphorylation.
Materials and methods
All experimental procedures were performed in accordance with UK legislation including the Animals (Scientific Procedures) Act 1986 and with approval of the University of Strathclyde Animal Welfare and Ethical Review Body (AWERB).
Mouse primary hippocampal culture
Mouse primary hippocampal cultures were prepared as described previously (Abdul Rahman et al., 2016) . Briefly, C57BL/6J pups (1-2 days old) were sacrificed by cervical dislocation and decapitated. Under sterile conditions, the hippocampi were removed, triturated and the resulting dissociated cells were plated at a density of 5.5 × 10 5 cells mL −1 onto 13 mm coverslips or 6 well plates both coated with poly-L-lysine (0.01 mg mL −1 ; Sigma, UK). Cultures were incubated in culture medium consisting of Neurobasal-A medium (phenol red free for Ca 2+ imaging, Invitrogen, Paisley, UK) supplemented with 2% (v/v) B-27 serum-free supplement (Invitrogen, Paisley, UK) and 2 mM L-glutamine (Invitrogen, Paisley, UK) and maintained in a humidified incubator at 37°C/5% CO2 for 11-14 days in vitro (DIV) prior to functional studies. Cytosine β-D-arabinofuranoside (1 μM; Sigma, UK) was added at 5 DIV to prevent further glial cell proliferation. All experiments were performed on cells taken from at least three separate cultures obtained from different animals.
Lymphocyte preparation and ELISA
Popliteal, inguinal, axillary, brachial, cervical and mesenteric lymph nodes were harvested from C57BL/6J mice (8-10 weeks old) and transferred to Neurobasal-A culture medium. The lymph nodes were homogenised, passed through a cell strainer (70 μm; Corning Falcon, UK) and transferred to a 15 mL sterile tube, then centrifuged at 400 ×g for 5 min. Cells were washed twice and plated at a density of 4 × 10 6 cells mL −1 and maintained in hippocampal conditioned medium (HCM; culture medium from 11 to 14 day old hippocampal cultures) in a humidified incubator at 37°C/5% CO 2 for 18 h. Lymphocyte conditioned medium (LCM) was then collected, with mouse IFN-γ and IL-16 protein levels determined by ELISA according to manufacturer's instructions (eBiosciences and R&D Systems UK, respectively) using the following capture antibodies (anti-mouse IFN-γ; #14-7313-85 and rat anti-mouse IL-16; #842373) and detection antibodies (biotinylated anti-mouse IFN-γ, #13-7312-85 and biotinylated goat anti-mouse IL-16, #842374).
Ca 2+ imaging
Calcium imaging experiments were performed on hippocampal cultures (11-14 DIV) as previously described (Tinning et al., 2018) . Prior to imaging, cells were loaded with Fura-2 AM (1 μM; Invitrogen, UK) for 1 h in a humidified incubator at 37°C/5% CO 2 , whilst simultaneously being treated with either vehicle or rIL-16 (300 pg mL −1 , #RP8610; Thermo Fisher, UK). Cultures were then washed three times in HEPES-buffered saline (HBS) consisting of the following (in mM): NaCl 140, KCl 5, MgCl 2 2, CaCl 2 2, HEPES 10, D-glucose 10, pH 7.4 ± 0.02, 310 ± 2 mOsm. Throughout imaging, cultures were perfused with HBS at a rate of 3-3.5 mL min −1 with all drug solutions being added via the perfusate. Cultures were placed in a perfusion bath under a 20×/0.5 water dipping objective lens (Olympus UMPlanFl, Tokyo, Japan) on an upright widefield epifluorescence microscope (Olympus BXW51, Japan) with ratiometric images (350/380 nm; OptoLED, Cairn Research, UK) taken at 0.5 Hz from the neuronal soma and astrocytes using WinFluor imaging software (J. Dempster, University of Strathclyde). Cells were identified as neurons and astrocytes based on their morphological characteristics and their response to ADP and/or high extracellular KCl.
Electrophysiology
Mouse primary hippocampal cultures (11-14 DIV) were treated with vehicle, rIL-16 (300 pg mL −1 , #RP8610; Thermo Fisher, UK) or denatured rIL-16 (rIL-16 boiled for 1 h at 90°C) for 1 h in a humidified incubator at 37°C/5% CO 2 . Cultures were then washed with HBS and placed in a recording chamber and perfused continuously with HBS (1-2 mL min −1 ). Fire polished borosilicate glass microelectrodes (4-6 MΩ, Harvard Apparatus, UK) were filled with an internal solution containing (in mM): KMeSO 3 130, KCl 20, HEPES 10, EGTA 0.5, Mg-ATP 4 and Na-GTP 0.3, pH 7.2 ± 0.02, 290 ± 2 mOsm. All experiments were performed at room temperature (21-23°C) using an Axopatch-200B amplifier (Molecular Devices, USA) connected to a personal computer interfaced with Digidata 1322A interface (Molecular Devices, USA) and captured using Clampex 9.2 software (Molecular Devices, USA). For current-voltage relationships, cells were held at −70 mV in voltage clamp mode with 10 mV increments for 200 ms at 10 s intervals with Na + current measured as the peak inward current at each voltage step and the K + current measured as the peak steady state outward current at the last 10 ms of each voltage step. Spontaneous excitatory postsynaptic currents (sEPSCs), digitized at 5 kHz, were recorded at -70 mV for 3-minute periods in voltage-clamp mode. Data were analysed offline using Clampfit 10.2 software (Molecular Devices, USA) and MiniAnalysis software (Synaptosoft, USA).
Immunostaining
2.5.1. Immunohistochemistry C57BL/6J mice (6-8 weeks old) were sacrificed by cervical dislocation, perfused with phosphate buffered saline (PBS) following which the brain was removed and snap frozen in OCT. Brain sections (7 μm) were cut using a cryostat (Shandon, Thermo Fisher, UK) and then stained with a primary antibody against IL-16 (1:400, #PA5-20670; Thermo Fisher, UK) or CD4 (RM4-5, 1:400, 14-0042-85; eBioscience, UK), followed by incubation with an appropriate biotinconjugated secondary antibody (#550338; BD Pharmingen, UK), horseradish peroxidase and ImmPACT™ AMEC red peroxidase substrate (Vector Laboratories, UK). Isotypes with matching IgG were used as negative controls for all antibody staining. Slides were visualized using a Nikon Eclipse 50 microscope with a Nikon Digital Sight DS-U3 camera using NIS Element F3.2 imaging software (Nikon Instruments, UK).
Immunocytochemistry
Mouse primary hippocampal cultures (11-14 DIV) were fixed with ice-cold 4% (v/v) paraformaldehyde for 10 min, followed by ice-cold 100% methanol for 10 min. Subsequently, cells were permeabilised with Triton-X (0.01% (v/v), Sigma, UK) in blocking solution (5% foetal bovine serum (FBS) v/v and BSA (0.01 g mL −1 ) in PBS, all Sigma, UK) for 10 min, followed by incubation in blocking solution alone for a further 20 min. Cultures were then incubated with primary antibodies against MAP2 (1:500, #AB5543; Millipore, UK), GFAP (GA5, 1:500, #3670; Cell Signaling Technologies, The Netherlands), CD4 (RM4-5, 1:400, 14-0042-85; eBioscience, UK) and CD45 (1:5000, #Ab10558; Abcam, UK) diluted in blocking solution at 4°C overnight. The cells were then washed with blocking solution and incubated with the corresponding fluorescently-conjugated secondary antibodies (Alexa Fluor 488 and Alexa Fluor 555, 1:200, Thermo Fisher, UK) in blocking solution for 1 h at room temperature. Cultures were then washed and images acquired using an Olympus BXW51 microscope with a Q- ] i levels are reduced by rIL-16 (300 pg mL −1 , 1 h), whereas no effect was observed in astrocytic [Ca 2+ ] i levels. *P < 0.05 vs vehicle control, ***P < 0.001 vs hippocampal conditioned media (HCM) control. Data are mean ± S.E.M, with n = 3 for ELISA and n ≥ 100 cells for Ca 2+ imaging with each data set taken from at least 3 different cultures.
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Western blot
Mouse primary hippocampal cultures (11-14 DIV) grown in 6 well plates were treated with either vehicle or rIL-16 (300 pg mL −1 , #RP8610, Thermo Fisher, UK) for 1 h in a humidified incubator at 37°C/5% CO 2 , then washed in ice-cold PBS and lysed in lysis buffer consisting of (in mM): Tris 50, NaCl 150, EDTA 1, Triton X-100 (1% v/ v), deoxycholate (0.05% v/v), pH 7.4 ± 0.02, containing a phosphatase and protease inhibitor cocktail (Sigma Aldrich). Lysates were then centrifuged at 16,000 rpm for 10 min. Equal amounts of protein were heated to 95°C in SDS sample buffer for 5 min, resolved by SDS-PAGE and transferred to nitrocellulose for immunoblotting analysis. Blots were incubated overnight at 4°C with primary antibodies against total GluA1 (1:1000, #ab109450; Abcam, UK), GluA1 phospho S845 (1:1000, #ab76321; Abcam, UK), GluA1 phospho Ser831 (1:1000, #04-823; Millipore, UK), pan sodium channel (1:500, #SAB4502713; Sigma, UK), CD4 (RM4-5, 1:400, 14-0042-85; eBioscience, UK) or CD9 (1:500, #ab92726; Abcam, UK). Membranes were then washed in PBS-Tween (0.1%) for 20 min, followed by incubation with corresponding secondary antibodies (IR dye, 1 h, 1:10,000; LI-COR, UK). Blots were scanned using an Odyssey scanner (LI-COR, UK) and bands were analysed and quantified using Image Studio Live 5.2 software (LI-COR, UK).
Statistics
All data are expressed as mean ± S.E.M. Data were compared by unpaired Student's t-tests, one-way or two-way analysis of variance with Bonferroni's comparison as appropriate, with differences considered significant when P < 0.05.
Results

IL-16 reduces pharmacologically-induced increases in neuronal but not astrocytic intracellular Ca
2+
In agreement with our previous findings (Shrestha et al., 2014) , conditioned media from mouse lymphocyte preparations contains IL-16. Following an 18 h incubation, LCM contains 360 ± 51 pg mL −1 (p < 0.001 vs HCM, n = 3 hippocampal cultures; Fig. 1A ) whereas in contrast, IL-16 is undetectable in HCM. Furthermore, we confirmed that other cytokines, including IFN-γ, were below detectable levels under our experimental conditions. Hence, we utilised rIL-16 (300 pg mL 
rIL-16 treatment significantly reduces sEPSC frequency and amplitude and decreases GluA1 S831 phosphorylation
Having established that rIL-16 impairs glutamate-induced n [Ca 2+ ] i elevations, we investigated the effect of rIL-16 exposure on synaptic activity by monitoring sEPSCs. rIL-16 (300 pg mL −1 , 1 h) impaired sEPSC frequency to 21.6 ± 6.4% of vehicle control (n = 8, p < 0.001. Fig. 2A-C) , an effect that was absent when rIL-16 was denatured (dIL-16) prior to application (97.0 ± 16.0% of vehicle control, n = 6 neurons, Fig. 2A-C) . In addition, rIL-16 exposure reduced sEPSC amplitude (58.3 ± 6.0% of vehicle control, n = 8 neurons, p < 0.05, Fig. 2A , B & D) with dIL-16 exposure having no effect (99.5 ± 7.2% of vehicle control, n = 6 neurons). With IL-16 significantly reducing both the frequency and amplitude of sEPSCs compared to vehicle controls, we examined GluA1 subunit expression and its phosphorylation state following exposure to rIL-16. GluA1 S831 phosphorylation was decreased in rIL-16 (300 pg mL −1 , 1 h) treated cultures (54.8 ± 6.7% of vehicle control, n = 3, p < 0.05, Fig. 2E & F) whereas total GluA1 (105.1 ± 27.4% of vehicle control, n = 3) and GluA1 S831 phosphorylation (74.1 ± 19.3% of vehicle control, n = 3) were unaffected by rIL-16 treatment.
rIL-16 reduces Na + channel function but not expression in mouse hippocampal neurons
Having established that rIL-16 impairs sEPSC frequency and , 1 h) on sEPSC frequency and amplitude respectively. (E + F) Representative images and bar chart revealing the effects of rIL-16 (300 pg mL −1 , 1 h) on GluA1 S831 phosphorylation. *P < 0.05 vs vehicle control, ***P < 0.001 vs vehicle control. Data are mean ± S.E.M, with n ≥ 6 for sEPSC data and n = 3 for Western blot data taken from at least 3 different cultures.
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amplitude, we examined whether IL-16 modulation of Na + and K + channel function also contributed to these effects. rIL-16 (300 pg mL −1 , 1 h, n = 16) significantly impaired Na + current density (F = 37.74, P < 0.001, Fig. 3A & C) compared to vehicle controls (n = 15) with peak Na + current density (at -40 mV) being 9.7 ± 1.8% of vehicle control (n = 16, p < 0.001, Fig. 3A & C) . rIL-16-induced inhibition of Na + current density was partially reversed upon a 3 h washout (n = 9, F = 4.63, P < 0.05) with peak Na + current density being 40.5 ± 6.9% of vehicle control (n = 16, P < 0.05, Fig. 3C ). Analogous to the effects observed on sEPSC frequency and amplitude, exposure to dIL-16 had no effect on Na + current density with peak Na + current density being 103.2 ± 11.1% of vehicle control (n = 9, Fig. 3C ). In contrast to the effects of IL-16 on Na + current density, K + current density was unaffected following rIL-16 exposure with peak K + current density (at +30 mV) being 82.6 ± 16.4% of vehicle control ( Fig. 3B & D) . Having established that rIL-16 significantly reduced Na + current density, we examined whether this effect is due to altered Na + channel expression. However, rIL-16 treatment (300 pg mL −1 , 1 h) revealed no change in total Na + channel expression (89.8 ± 8.2% of vehicle control, n = 3, Fig. 2E & F) when compared to vehicle control.
IL-16 actions in primary hippocampal cultures is CD4-and CD9-independent
Having shown that IL-16 exposure impairs neuronal excitability and synaptic activity and given that IL-16 is proposed to mediate its effects via CD4-dependent and -independent mechanisms as well as potentially via CD9 (Kurschner and Yuzaki, 1999; Fenster et al., 2010; Yadav et al., 2010; Blake et al., 2018) , we examined CD4 and CD9 expression in our primary hippocampal cultures. Using immunocytochemistry, we observed CD4 expression in neither astrocytes nor neurons under our experimental conditions (Fig. 4A-D) , whereas positive CD4 staining was evident in control lymphocyte preparations (Fig. 4E-G) . Furthermore, both CD4 and CD9 protein expression was completely absent from our hippocampal cultures when examined using Western blots. In addition, we also examined IL-16 expression in the brain. In agreement with previous findings regarding NIL-16 (Kurschner and Yuzaki, 1999) , we observed IL-16 expression in the hippocampus and cerebellum, but in many other brain regions as well. IL-16 expression was present in all hippocampal sub-regions including the dentate gyrus (DG) and CA1-CA4 regions (Fig. 4H & I) . In contrast, CD4 staining was absent from all , 1 h) inhibits Na + current density. (B) IeV curve revealing no effect of rIL-16 (300 pg mL −1 , 1 h) on K + current density. (C) Bar chart summarising the effect of rIL-16 on peak Na + current density. (D) Bar chart summarising no effect of rIL-16 on peak K + current density. ***P < 0.001 vs vehicle control, #P < 0.05 vs rIL-16. Data are mean ± S.E.M, with n ≥ 9 for each data set taken from at least 3 different cultures.
hippocampal regions and from all brain regions examined ( Fig. 4J & K) .
Discussion
In the present study, we show that IL-16 impairs glutamate-induced increases in neuronal intracellular calcium and reduces synaptic activity in mouse hippocampal neurons, effects that are independent of its proposed receptors, CD4 and CD9. Furthermore, we provide evidence that reduced GluA1 phosphorylation and an inhibition of Na + channel function are potential mechanisms that may underlie these IL-16-mediated effects.
IL-16 impairs glutamate-induced increases in neuronal intracellular Ca 2+ levels
In agreement with our previous studies, IL-16 levels were elevated in LCM compared to hippocampal media controls, with other cytokine levels being below detectable levels (Shresha et al., 2014; Ritchie et al., 2018). Hence, we utilised rIL-16 at these quantified levels to examine the consequence of IL-16 exposure on neuronal excitability and synaptic activity in order to give us further insight into the role of IL-16 in modulating CNS function. Application of IL-16 alone did not induce an increase in either neuronal or astrocytic [Ca 2+ ] i , which is in contrast to previous studies in T cells where IL-16 induces increases in [Ca 2+ ] i via IP 3 generation in a CD4-dependent manner (Cruickshank and Center, 1982) . Whilst, to the best of our knowledge, this is the first study looking at IL-16 and Ca 2+ modulation within a CNS preparation, other cytokines including IL-1β and TNF-α have been shown to modulate [Ca 2+ ] i via a number of mechanisms depending on the cell preparation used (Furukawa and Mattson, 1998; Wuchert et al., 2009; Ghosh et al., 2016) . In contrast to the lack of effect on [ (Pál, 2018; Rose et al., 2018) , our data may indicate that IL-16 selectively modulates neuronally expressed ionotropic glutamate receptors.
IL-16 reduces the frequency and amplitude of spontaneous EPSCs
As IL-16 selectively impairs glutamate-induced increases in neuronal [Ca 2+ ] i , we next examined whether IL-16 altered synaptic activity, which is accepted to be glutamate receptor-mediated within hippocampal cultures. Exposure of mouse hippocampal cultures to IL-16, under the same conditions that impaired glutamate-induced Ca 2+ levels, resulted in a significant decrease in both sEPSC frequency and amplitude. This is the first direct evidence that IL-16 modulates synaptic activity, with both sEPSC frequency and amplitude being reduced, indicating a postsynaptic mechanism of action. This was further confirmed with the finding that GluA1 S831 phosphorylation was reduced with no effect observed on S845 phosphorylation or total GluA1. With GluA1 phosphorylation required for expression in the postsynaptic membrane (Henley and Wilkinson, 2016) , our data indicates that reduced postsynaptic GluA1 expression may be a potential mechanism by which IL-16 modulates sEPSCs. Whilst this is the first time that IL-16 has been shown to modulate GluA1, other glutamate receptor subtypes are known to interact with IL-16. Indeed NIL-16 co-immunoprecipitates with the NR2A NMDA subunit when both are overexpressed in cell lines, a finding proposed to be due to NIL-16's PDZ domains (Kurschner and Yuzaki, 1999) . The modulation of glutamate receptor function and expression is not unique to IL-16, with other cytokines including IL-1β and TNF-α modulating glutamate receptor function and expression (O'Connor and Coogan, 1999; Viviani et al., 2003; Yang et al., 2005; Liu et al., 2013; Wigerblad et al., 2017) . However, in contrast to the reduced GluA1 surface expression induced by IL-16, both IL-1β and TNF-α increase AMPA and NMDA receptor expression and function. Thus, modulation of glutamate receptors may be a common mechanism of action utilised by many cytokines but may be cytokine and region dependent. However, when cultured cerebellar granule neurons (CGN) were exposed to IL-16, this induced expression of the immediate early gene, c-fos, (Kurschner and Yuzaki, 1999; Fenster et al., 2010) . Given that c-fos expression is an indirect marker of increased neuronal activity (Gallo et al., 2018) , these data could suggest that IL-16 increases CGN activity. However, no direct electrophysiological measurements were made to examine this, although increased CGN neurite growth was observed, but how this relates to the current findings remains unclear. It should also be noted that the current study focussed solely on sEPSCs, whereas the effects of IL-16 on inhibitory transmission remains unknown. Therefore, any future studies should determine whether IL-16 displays any selectivity in its action on neurotransmitter receptors but this is beyond the scope of the present study.
IL-16 impairs Na + channel function
Whilst sEPSCs are mediated by spontaneous glutamate release acting on postsynaptic receptors, synaptically-driven action potential firing also contributes to the spontaneous neurotransmitter release observed in hippocampal cultures (Gan et al., 2011; Chanaday and Kavalali, 2018 (Liu et al., 2006; Zhou et al., 2011) and TNF-α (Chen et al., 2015; Leo et al., 2015) . In contrast to our knowledge regarding Na + channel function, NIL-16 interacts with multiple K + channel subtypes including members of the Kir2 and Kir4 family via its PDZ domain (Kurschner and Yuzaki, 1999) . Furthermore, Kv4.2 expression is reduced in the presence of NIL-16 in both COS-7 and hippocampal neurons (Fenster et al., 2007) . However, in the present study, IL-16 exposure has no effect on the steady state outward potassium current observed in hippocampal neurons. These data suggest that exposure to IL-16 (1 h) can impair neuronal excitability via inhibition of Na + channel function but is without effect on K + channel function. In future studies, it would be interesting to examine whether this inhibition is a direct effect on Na + channels or an indirect effect that develops over time but this is beyond the scope of the present study.
IL-16-mediated actions in mouse hippocampal neurons are CD4-and CD9-independent
Under our experimental conditions, CD4 and CD9 were absent in mouse hippocampal cultures, indicating that the observed effects were CD4-and CD9-independent. IL-16 is proposed to modulate neuronal function through both CD4-dependent and -independent pathways (Kurschner and Yuzaki, 1999; Fenster et al., 2010) . In a more recent study, CGNs were shown to express CD4 using Western blot and this was absent in CD4-deficient mice (Fenster et al., 2010) . Increases in cfos expression following IL-16 treatment were reduced in CD4-deficient mice, whereas increased neurite outgrowth was still present, highlighting that IL-16 mediates its effects through both CD4-dependent and -independent pathways. Furthermore, it has been proposed that IL-16's interaction with immune cells can also be CD4-independent (Mathy et al., 2000) , hence our finding that IL-16 mediates its effects in mouse hippocampal cultures via CD4-independent mechanisms is in agreement with this and further supports the idea that other receptors may exist for IL-16 function. Indeed, recent reports have proposed that CD9 may be an alternative receptor via which IL-16 mediates its actions when investigated in lung epithelial and cancer cells (Yadav et al., 2010; Blake et al., 2018) . However, our data reveals that similar to CD4, CD9 is not present within our hippocampal cultures and therefore does not underlie the IL-16-mediated effects observed in the present study. We also examined the reported selective IL-16 expression within the brain. In agreement with previous studies (Kurschner and Yuzaki, 1999) , we confirmed that IL-16 expression was present in the cerebellum and hippocampus, but also in other regions of the mouse brain. This expression pattern may be due to an IL-16 antibody that is not selective for NIL-16 but is nevertheless interesting given the proposed role of IL-16 in MS and EAE, with IL-16 proposed as a key regulator of the CD4 + T cell mediated immune response in these conditions (Skundric et al., 2015) . Given that the cerebellum, and to a lesser extent the hippocampus, are the brain regions where immune cell infiltration occurs in the EAE model (Hridi et al., unpublished observations), our data support the notion that IL-16 may indeed play a key role as a chemoattractant in this inflammation-related CNS disease.
In summary, we provide evidence that exposure of mouse primary hippocampal cultures to IL-16 impairs neuronal excitability and synaptic activity via CD4-and CD9-independent mechanisms. These data extend our current understanding of how IL-16 modulates CNS function and highlight that IL-16 does not function solely via CD4-and CD9-dependent mechanisms, but indicates that alternative targets may be involved.
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